Phase II trial of Eribulin/S-1 combination therapy for advanced/recurrent breast cancer

被引：0
|
作者：
Iwasa, Tsutomu [1 ]
Komoike, Yoshifumi [7 ]
Tsurutani, Junji [1 ]
Nakagawa, Kazuhiko [1 ]
Mizuno, Yutaka [2 ]
Matsunami, Nobuki [3 ]
Yamamura, Jun [4 ]
Otani, Shoichiro [5 ]
Kojima, Yasuyuki [6 ]
Watanabe, Satomi [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
[2] Yokkaichi Municipal Hosp, Dept Breast Surg, Yokaichi, Japan
[3] Osaka Rosai Hosp, Dept Breast Surg, Sakai, Osaka, Japan
[4] Sakai City Med Ctr, Dept Breast & Endocrine Surg, Sakai, Osaka, Japan
[5] Hiroshima City Hiroshima Citizens Hosp, Dept Breast Surg, Hiroshima, Japan
[6] St Marianna Univ, Sch Med, Dept Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan
[7] Kinki Univ, Fac Med, Dept Breast & Endocrine Surg, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-15-2
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of eribulin and S-1 combination therapy for advanced or recurrent breast cancer
    Iwasa, T.
    Tsurutani, J.
    Mizuno, Y.
    Kojima, Y.
    Takashima, T.
    Matsunami, N.
    Morimoto, T.
    Yamamura, J.
    Ohtani, S.
    Tanabe, Y.
    Watanabe, S.
    Kato, R.
    Tanino, H.
    Tokunaga, S.
    Abe, H.
    Tsuyuki, S. T.
    Hara, F.
    Takano, T.
    Komoike, Y.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2017, 28 : 28 - 28
  • [2] PHASE I TRIAL OF ERIBULIN/S-1 COMBINATION THERAPY FOR ADVANCED/RECURRENT BREAST CANCER
    Iwasa, Tsutomu
    Sakiyama, Tsutomu
    Tsurutani, Junji
    Tanaka, Kaoru
    Yoshida, Takeshi
    Nonagase, Yoshikane
    Fujisaka, Yasuhito
    Kurata, Takayasu
    Komoike, Yoshifumi
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Phase I trial of eribulin in combination with S-1 for advanced and recurrent breast cancer patients
    Iwasa, Tsutomu
    Tsurutani, Junji
    Nishida, Satomi
    Komoike, Yoshifumi
    Nakagawa, Kazuhiko
    CANCER RESEARCH, 2015, 75
  • [4] Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
    Tsutomu Iwasa
    Junji Tsurutani
    Satomi Watanabe
    Ryoji Kato
    Yutaka Mizuno
    Yasuyuki Kojima
    Tsutomu Takashima
    Nobuki Matsunami
    Takashi Morimoto
    Jun Yamamura
    Shoichiro Ohtani
    Yuko Tanabe
    Tetsuhiro Yoshinami
    Toshimi Takano
    Yoshifumi Komoike
    Kazuhiko Nakagawa
    BMC Cancer, 19
  • [5] Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
    Iwasa, Tsutomu
    Tsurutani, Junji
    Watanabe, Satomi
    Kato, Ryoji
    Mizuno, Yutaka
    Kojima, Yasuyuki
    Takashima, Tsutomu
    Matsunami, Nobuki
    Morimoto, Takashi
    Yamamura, Jun
    Ohtani, Shoichiro
    Tanabe, Yuko
    Yoshinami, Tetsuhiro
    Takano, Toshimi
    Komoike, Yoshifumi
    Nakagawa, Kazuhiko
    BMC CANCER, 2019, 19 (01)
  • [6] Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer
    Yoshida, Kazuhiro
    Ninomiya, Motoki
    Takakura, Norihisa
    Hirabayashi, Naoki
    Takiyama, Wataru
    Sato, Yuji
    Todo, Satoru
    Terashima, Masanori
    Gotoh, Mitsukazu
    Sakamoto, Jyunnichi
    Nishiyama, Masahiko
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3402 - 3407
  • [7] Phase II Study of Biweekly Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
    Kakeji, Yoshihiro
    Oki, Eiji
    Egashira, Akinori
    Sadanaga, Noriaki
    Takahashi, Ikuo
    Morita, Masaru
    Emi, Yasunori
    Maehara, Yoshihiko
    ONCOLOGY, 2009, 77 (01) : 49 - 52
  • [8] Phase II trial of eribulin in advanced/recurrent cervical cancer
    Garcia-Sayre, Jocelyn
    Lin, Yvonne
    Matsuo, Koji
    Tsao-Wei, Denice
    Mhawech-Fauceglia, Paulette
    Louie, Stan
    Dong, Tiang
    Ciccone, Marcia
    Brunette, Laurie
    Pham, Huyen
    Yessaian, Annie
    Groshen, Susan
    Facio, Grace
    Aldana, Marissa
    Muderspach, Laila
    Garcia, Agustin
    Roman, Lynda
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S69 - S70
  • [9] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
12345